Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Inventory: 2024-2025

Historic Inventory for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Sep 2025 value amounting to $471,000.

  • Insight Molecular Diagnostics' Inventory rose 103.02% to $471,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $471,000, marking a year-over-year increase of 103.02%. This contributed to the annual value of $410,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Inventory is $471,000, which was down 32.03% from $693,000 recorded in Q2 2025.
  • Insight Molecular Diagnostics' Inventory's 5-year high stood at $693,000 during Q2 2025, with a 5-year trough of $232,000 in Q3 2024.
  • Over the past 2 years, Insight Molecular Diagnostics' median Inventory value was $459,000 (recorded in 2025), while the average stood at $453,000.
  • Data for Insight Molecular Diagnostics' Inventory shows a peak YoY spiked of 103.02% (in 2025) over the last 5 years.
  • Insight Molecular Diagnostics' Inventory (Quarterly) stood at $410,000 in 2024, then soared by 103.02% to $471,000 in 2025.
  • Its last three reported values are $471,000 in Q3 2025, $693,000 for Q2 2025, and $459,000 during Q1 2025.